News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Job Trends
Merck & Co., Inc. To Close 16 Facilities As Part Of Schering-Plough Corporation Integration; Plan to Reduce Workforce by 15% or 15,000
July 8, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK July 8 (Reuters) - Merck & Co (MRK.N) announced plans on Thursday to close eight research sites and eight manufacturing sites as it restructures in the wake of its merger with rival drugmaker Schering-Plough Corp.
Twitter
LinkedIn
Facebook
Email
Print
Job creations
People
Merck & Co.
MORE ON THIS TOPIC
C-suite
Stoffels To Depart Galapagos, Short of Five-Year Mission To Remake the Biotech
April 22, 2025
·
2 min read
·
Annalee Armstrong
Layoff Tracker
Tempest Axes 80% of Workforce
April 22, 2025
·
180 min read
·
BioSpace Editorial Staff
Layoffs
Tempest Cuts 80% of Staff While Considering Strategic Alternatives
April 21, 2025
·
1 min read
·
Angela Gabriel
Layoffs
Q1 Biopharma Layoffs Hit California, Massachusetts Hard
April 17, 2025
·
5 min read
·
Angela Gabriel